|Bid||2.4600 x 36200|
|Ask||2.4700 x 1300|
|Day's Range||2.3800 - 2.5200|
|52 Week Range||1.0100 - 6.4500|
|Beta (5Y Monthly)||1.24|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 19, 2021 - Jul 23, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In this article, we will take a look at the 10 best weed stocks to buy now. You can skip our comprehensive analysis of the cannabis industry and go directly to the 5 Best Weed Stocks to Buy Now. While the coronavirus pandemic has wreaked havoc on many industries around the world, the weed industry proved […]
Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Borna Zlamalik as the Company’s Vice President of Innovation. Mr. Zlamalik will assume his new role effective today.
The only company-specific news around OrganiGram came earlier this week when the company surprised investors with news that CEO Greg Engel will be leaving that role immediately and that his interim replacement is the board's chairman, Peter Amirault. Jefferies analyst Owen Bennett upgraded fellow Canadian cannabis company Tilray (NASDAQ: TLRY) today with a double bump up to a buy rating. Bennett assigned Tilray a price target representing more than 60% upside in the name.